Neuravi has announced that Robert Colloton has joined the company’s senior management team as vice president of US Sales and Marketing.
According to a company release, Colloton brings 25 years of experience in medical device sales and market development and branding, particularly in the neurovascular market. Most recently, he was vice president of Marketing and Sales at Revision Optics. Previously, he served as vice president of Global Sales and Marketing at Micrus Endovascular, where he built the sales team and grew the business. He has also held senior leadership positions in sales and marketing at VNUS Medical, TransVascular, and Cardiometrics.
“Enrolment in our ARISE II clinical study of the EmboTrap revascularisation device is progressing ahead of our plan, so this is the right time for Neuravi to invest in building the leadership team for our US program,” says Eamon Brady, chief executive officer.
“I am eager to be re-entering the neurovascular market, especially at this exciting time of tremendous growth in acute ischaemic stroke treatment,” says Colloton.